Fiche centre
Lishui Central Hospital
Lishui — China
Essais liés4clinical trials
VilleLishuilocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07509645
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Maridebart cafraglutide | Insuffisance cardiaque | Phase 3 | NCT07037459 | MARITIME-HF — Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity | RECRUITING |
| Qishen Yiqi Dripping Pills 2 bags | Insuffisance cardiaque | Phase 3 | NCT07687186 | Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre | RECRUITING |
| Anisodine Hydrobromide | Accident vasculaire cérébral | Phase 2 | NCT07800572 | Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL-2) | RECRUITING |
| Tocilizumab | Accident vasculaire cérébral | Phase 3 | NCT07509645 | IRIS-3 — Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Posterior Circulation Large Vessel Occlusion Stroke | RECRUITING |